Mark Kotter

On this episode, Mark Kotter, CEO of Bit.bio, discusses the concept of programmable biology and the challenges involved in building capabilities. They delve into the interdisciplinary team required, the innovative cell reprogramming at Bit.bio, focusing on regenerative medicine indications, funding journey, stem cell reprogramming for aging interventions, and visibility in the biotech space.

Mark Kotter, founder of clock.bio and CEO of bit.bio, discusses the potential of using human pluripotent stem cells to reverse the harmful effects of time in our cells. The podcast covers the development of aging models, unbiased CRISPR screens, and the identification of gene candidates for cell rejuvenation. The goal is to extend health span by 20 years and create novel treatment approaches based on biomarkers of aging.